Skip to content

Resolve Therapeutics, LLC.

About Us
Pipeline
- Our Pipeline
Science
Sjögren’s Clinical Trial
Publications
News

Follow us on:

Linkedin page opens in new window Facebook page opens in new window

About Us
Pipeline
- Our Pipeline
Science
Sjögren’s Clinical Trial
Publications
News

Peter Kiener, Ph.D.

Peter Kiener, Ph.D.

read more

Peter Kiener, Ph.D.

Venture Partner
ICG Life Science

Close

Search:

Recent Posts

Resolve Therapeutics Publishes Results of RSLV-132 Phase 2 Long COVID Study
Assessment of the Impact of RNase in Patients With Severe Fatigue Related to Post-Acute Sequelae of SARS-CoV-2 Infection (PASC): A Randomized Phase 2 Trial of RSLV-132
Resolve Therapeutics Announces Publication of Lupus Clinical Trial Results
Evaluation of RNase therapy in systemic lupus erythematosus: a randomised phase 2a clinical trial of RSLV-132
Resolve Therapeutics Completes Enrollment of Phase 2 Long Covid Clinical Trial

Resolve Therapeutics, LLC
1951 NW 7th Ave.
Suite 300
Miami, FL 33136

© 2020 Resolve Therapeutics. All rights reserved.

Sitemap Terms of Use Privacy Policy